References
Mathews, Ronnie E. et al. Outpatient Management of Cirrhosis: A Narrative Review. Southern Medical Journal. June 2006; 99: 600-606.
Fattovich G, Giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463-472.
Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study: the North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 1988; 319: 983-989.
Poynard T, Cales P, Pasta L, et al. Beta-adrenergic-antagonists drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices: an analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 1991; 324: 1532-1538.
McGuire BM, Bloomer JR. Complications of cirrhosis: why they occur and what to do about them. Postgrad Med 1998; 103:209-12, 217- 8, 223-224.
Gines P, Rimola A, Planas R, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990;12:716-24.
Gebo KA, Chander G, Jenckes MW, et al. Screening tests for hepatocellular carcinoma in patients with chronic hepatitis C: a systematic review. Hepatology 2002;36:S84-S92.
Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473-479.
Tong W, Hurley S, Hayashi PH. Reconsidering hepatorenal syndrome: throw in the towel? Not so fast! Postgrad Med 2004; 116:15-6, 21-24.
Schenk P, Schoniger-Hekele M, Fuhrmann V, et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003;125:1042-1052.
Murray KF, Carithers RL Jr. ASLD practice guidelines: evaluation of the patient for liver transplantation. Hepatology 2005; 41:1407-1432.
Petta, Salvatore and Antonio Craxi. Therapeutic algorithms for chronic hepatitis C in the DAA era during the current economic crisis: whom to treat? How to treat? When to treat? BMC Infectious Diseases2012, 12(Suppl2):S3.
Kim, Arthur Y. Management Algorithm for genotype I. F1000 Prime Reports2013, 5:24.
EASL Clinical Practice Guidelines for management of patients with decompensated cirrhosis. Journal of Hepatology2018 vol. 69 (406-460).
Recorded October 15, 2019 The American Liver Foundation along with Dr. AnnMarie Liapakis of the Yale New Haven Transplantation Center presents a compelling view of Cirrhosis and its treatment. This presentation is for those who seek to understand more about the progression of liver disease and it's stages.